Long-Term Outcomes of Stereotactic Radiosurgery for Pineocytomas: An International Multicenter Study

医学 放射外科 期限(时间) 医学物理学 多中心研究 梅德林 放射科 外科 放射治疗 随机对照试验 天文 物理 政治学 法学
作者
Andréanne Hamel,Jean-Nicolas Tourigny,Ajay Niranjan,L. Dade Lunsford,Zhishuo Wei,Priyanka Srinivasan,Roman Liščák,Jaromír May,Nuria Martínez Moreno,Roberto Martínez Álvarez,Cheng‐Chia Lee,Huai‐Che Yang,Manjul Tripathi,Narendra Kumar,Elad Mashiach,Douglas Kondziolka,Robert G. Briggs,Cheng Yu,Gabriel Zada,Andrea Franzini,Guido Pecchioli,Gregory Bowden,Sam Dayawansa,Jason P. Sheehan,David Mathieu
出处
期刊:Neurosurgery [Oxford University Press]
标识
DOI:10.1227/neu.0000000000003261
摘要

BACKGROUND AND OBJECTIVES: Pineocytomas are grade 1 tumors arising from the pineal parenchyma. Gross total resection can potentially cure these benign lesions but can be associated with morbidity. This study was designed to provide multi-institutional data to evaluate the results of stereotactic radiosurgery (SRS) for pineocytomas. METHODS: Centers participating in the International Radiosurgery Research Foundation were asked to review their database and provide data for patients who had SRS for histology confirmed grade 1 pineocytomas, for whom clinical and imaging follow-up of at least 6 months was available. RESULTS: In total, 38 patients underwent SRS as part of the management of a pineocytoma. The median age at SRS was 39 years (range 8-76). SRS was performed as primary approach in 68%, adjuvant after partial resection 19%, and at recurrence in 13% of patients. The median margin dose was 15 Gy (range 11-25 Gy). The median treatment volume was 3.35 cc (range 0.1-17.9 cc). Local tumor control was achieved in 92% of patients, with a mean actuarial progression-free survival of 21.6 years (median not reached). At last follow-up, 82% were still controlled, 8% had local recurrence, and 10% had cerebrospinal fluid dissemination. Tumor control was significantly better when SRS was used as primary care compared with the adjuvant or recurrent setting ( P = .016). Five patients (13%) died during follow-up, all from tumor progression. The actuarial mean survival duration was 24.3 years, with a 5-year survival rate of 91%, and an estimated rate of 76% at 29 years. Larger tumor volume at SRS was found to be correlated to increased risk of death ( P = .045). Transient symptomatic adverse radiation effects were observed in 4 patients (11%). CONCLUSION: SRS appears safe and effective for the management of pineocytomas. Long-term tumor control is achieved in most cases. SRS can be offered to selected patients as an alternative to surgical resection.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慢慢发布了新的文献求助10
2秒前
xu完成签到,获得积分10
9秒前
丘比特应助念念采纳,获得10
10秒前
11秒前
西葫芦莲子粥完成签到,获得积分10
12秒前
听白完成签到 ,获得积分10
12秒前
13秒前
13秒前
老实幻姬发布了新的文献求助10
13秒前
搜集达人应助KKK采纳,获得10
13秒前
rzzz完成签到,获得积分10
14秒前
慢慢完成签到,获得积分10
15秒前
Yang发布了新的文献求助10
17秒前
Pepper发布了新的文献求助10
18秒前
19秒前
燕子发布了新的文献求助10
19秒前
20秒前
21秒前
孤独的根号三完成签到,获得积分20
21秒前
李银锋完成签到,获得积分10
22秒前
22秒前
不可思宇完成签到,获得积分10
22秒前
zlfan2197发布了新的文献求助10
24秒前
zby发布了新的文献求助10
24秒前
curtisness应助guozi采纳,获得20
25秒前
生动谷蓝完成签到,获得积分10
26秒前
燕子完成签到,获得积分10
26秒前
科研通AI2S应助lxx采纳,获得10
27秒前
MARK发布了新的文献求助10
27秒前
cm发布了新的文献求助10
28秒前
诸乘风发布了新的文献求助10
28秒前
28秒前
自然的飞鸟完成签到,获得积分10
28秒前
29秒前
99giddens给Web74的求助进行了留言
29秒前
甜甜戎发布了新的文献求助10
30秒前
屁颠屁颠_狼完成签到 ,获得积分0
31秒前
噗哈哈完成签到 ,获得积分10
32秒前
彭于彦祖应助xiaochouyu采纳,获得50
33秒前
KKK发布了新的文献求助10
33秒前
高分求助中
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 600
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufe 600
A Dissection Guide & Atlas to the Rabbit 600
Revolution und Konterrevolution in China [by A. Losowsky] 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3108991
求助须知:如何正确求助?哪些是违规求助? 2759776
关于积分的说明 7657017
捐赠科研通 2414379
什么是DOI,文献DOI怎么找? 1281314
科研通“疑难数据库(出版商)”最低求助积分说明 618565
版权声明 599445